Merck Failed To Probe Diabetes Drugs For Risks: FDA
By Erin Fuchs · February 28, 2012, 7:08 PM EST
The U.S. Food and Drug Administration warned Merck & Co. Inc. that it faces possible fines for missing a deadline by more than a year to probe pancreatitis risks tied to...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login